Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagus

Advanced Drug Delivery Reviews

Volumn 58, Issue 3, 2006, Pages 447-462

  Machan, Lindsay ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Gastrointestinal neoplasms; Interventional radiology; Peripheral catheterization; Peripheral vascular diseases; Stents

Indexed keywords

BIOMATERIALS; BIOMEDICAL ENGINEERING; DRUG PRODUCTS; DRUG THERAPY;

GASTROINTESTINAL NEOPLASMS; INTERVENTIONAL RADIOLOGY; PERIPHERAL CATHETERIZATION; PERIPHERAL VASCULAR DISEASES; STENTS;

BLOOD VESSELS;

ABCIXIMAB; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; COPOLYMER; CYCLOSPORIN A; ETHYLENE VINYL ACETATE COPOLYMER; HEPARIN; IMMUNOSUPPRESSIVE AGENT; LACTONE DERIVATIVE; MACROCYCLIC COMPOUND; NITINOL; PACLITAXEL; POLYMER; RAPAMYCIN; TACROLIMUS;

ARTERY OCCLUSION; ATHEROSCLEROSIS; BILE DUCT; BLOOD FLOW VELOCITY; BLOOD VESSEL WALL; CAROTID ARTERY; CATHETERIZATION; CLINICAL TRIAL; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DEVICE; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG FATALITY; ESOPHAGUS; GASTROINTESTINAL TUMOR; HUMAN; ILIAC ARTERY; INTERVENTIONAL RADIOLOGY; KIDNEY ARTERY STENOSIS; MEDICAL RESEARCH; NONHUMAN; PERIPHERAL VASCULAR DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; RENAL ARTERY; RESTENOSIS; REVIEW; SUPERFICIAL FEMORAL ARTERY; TIBIAL ARTERY; TRACHEA;

ANIMALS; BILE DUCTS; DRUG DELIVERY SYSTEMS; ESOPHAGUS; HUMANS; MICROCIRCULATION; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS; SIROLIMUS; STENTS;

EID: 33744539171     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2006.01.024     Document Type: Review

References (49)

1. Hedin M. The origin of the word Stent. Acta Radiol. 6 (1997) 937-939
2. Dorland's Illustrated Medical Dictionary. Philadelphia: W.B. Saunders Co.
3. Virmani R., and Farb A. Pathology of in-stent restenosis. Curr. Opin. Lipidol. 10 (1999) 499-506
4. Ong A.T., and Serruys P.W. Technology insight: an overview of research in drug-eluting stents. Nat. Clin. Pract. Cardiovasc. Med. 2 12 (2005 (Dec.)) 647-658
5. Sousa J.E., Serruys P.W., and Costa M.A. New frontiers in cardiology: drug-eluting stents: Part I. Circulation 107 (2003) 2274-2279
6. Dormandy J.A., and Rutherford R.B. Management of Peripheral Arterial Disease (PAD). TransAtlantic Inter-Society Consensus (TASC). J. Vasc. Surg. 31 (2000) S1-S296
7. Weinberger J. Diagnosis and prevention of atherosclerotic cerebral infarction. CNS Spectr. 10 7 (2005 (Jul.)) 553-564
8. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35 (2004) 1388-1392
9. Yamazoe N., Hashimoto N., Kikuchi H., et al. Study of the elastic skeleton of intracranial arteries in animal and human vessels by scanning electron microscopy. Stroke 21 5 (1990 (May)) 765-770
10. Serruys P.W., Foley D.P., Kirkeeide R.L., and King S.B. Restenosis revisited: insights provided by quantitative coronary angiography. Am. Heart J. 126 (1993) 1243-1267
11. Abou-Chebl A., Bashir Q., and Yadav J.S. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 36 12 (2005) e165-e168
12. Boulos A.S., Agner C., and Deshaies E.M. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol. Res. 27 Suppl. 1 (2005) S95-S102
13. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N. Engl. J. Med. 325 (1991) 445-453
14. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337 (1991) 1235-1243
15. Bosiers M., Peeters P., Deloose K., et al. Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stenting. Vascular 13 2 (2005 (Mar-Apr.)) 92-97
16. CaRESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J. Vasc. Surg. 42 (2005) 213-219
17. Mwipatayi B.P., Beningfield S.J., White L.E., et al. A review of the current treatment of renal artery stenosis. Eur. J. Vasc. Endovasc. Surg. 29 (2005) 479-488
18. Bokhari S.W., and Faxon D.P. Current advances in the diagnosis and treatment of renal artery stenosis. Rev. Cardiovasc. Med. 5 (2004) 204-215
19. Uder M., and Humke U. Endovascular therapy of renal artery stenosis: where do we stand today?. Cardiovasc. Interv. Radiol. 28 (2005) 139-147
20. Sapoval M., Zahringer M., Pattynama P., et al. Low-profile stent system for treatment of atherosclerotic renal artery stenosis: the GREAT trial. J. Vasc. Interv. Radiol. 16 (2005) 1195-1202
21. Rabbia C. The Palmaz Genesis Peripheral Stainless Steel Balloon Expandable Stent in REnal Artery Treatment (GREAT) trial. Presented at 2005 Cardiovascular and Interventional Radiology Society of Europe Annual Meeting, Nice, France (2005)
22. Marx S.O., and Marks A.R. The development of rapamycin and its application to stent restenosis. Circulation 104 (2001) 852-855
23. Zohlnhofer D., Klein C.A., Richter T., et al. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein upregulation. Circulation 103 (2001) 1396-1402
24. Roque M., Codon-Cardo C., Fuster V., et al. Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model. Atherosclerosis 153 (2000) 315-322
25. Gallo R., Padurean A., Jayaraman T., et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99 (1999) 2164-2170
26. www.tasc-pad.org.
27. Jamsen T.S., Manninen H.I., Jaakkola P.A., et al. Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology 225 (2002) 345-352
28. Jahnke T., Voshage G., Muller-Hulsbeck S., et al. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. JVIR 13 (2002) 257-266
29. Mewisson M.W. Nitinol stents in the femoropopliteal arterial segment. Endovasc. Today 2 (2003) 29-34
30. Smouse B. Changes in the femoral arteries during joint movement before and after stent placement in the cadaver model. Presented at the Society of Interventional Radiology 2005 Annual Meeting, New Orleans, LA (2005)
31. Arena F.J. Arterial kink and damage in normal segments of the superficial femoral and popliteal arteries abutting nitinol stents-a common cause of late occlusion and restenosis? A single-center experience. J. Invasive Cardiol. 17 (2005) 482-486
32. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J. Am. Coll. Cardiol. 45 (2005) 312-315
33. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106 12 (2002 (Sep. 17)) 1505-1509
34. Duda S.H., Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J. Vasc. Interv. Radiol. 16 (2005) 331-338
35. Farb A., Heller P.F., Shroff S., et al. Pathological analysis of local delivery of paclitaxel via a polymer-eluting stent. Circulation 104 (2001) 473-479
36. Rowinsky E.K., and Donehower R.C. Paclitaxel (taxol). N. Engl. J. Med. 332 (1995) 1004-1014
37. Gershlick A., De Scheerder I., Chevalier B., et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation 109 (2004) 487-493
38. Scheller B., Speck U., Abramjuk C., et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110 (2004) 810-814
39. Faglia E., Mantero M., Caminiti M., et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J. Intern. Med. 52 3 (2002) 225-232
40. Siablis D., Kraniotis P., Karnabatidis D., et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J. Endovascular Ther. 12 6 (2005) 685-695
41. Tepe G., Heller S., Wiesinger B., et al. Drug eluting stents versus PTA with GP IIb/IIIa blockade below the knee in patients with current ulcers-The BELOW-Study. Presented at 2005 Cardiovascular and Interventional Radiology Society of Europe Annual Meeting, Nice, France (2005)
42. Lemaire A., Burfeind W.R., Toloza E., et al. Outcomes of tracheobronchial stents in patients with malignant airway disease. Ann. Thorac. Surg. 80 (2005) 434-437
43. Mitton D., and Ackroyd R. Oesophageal stenting. Scand. J. Gastroenterol. 40 (2005) 1-14
44. Kozarek R. Metallic biliary stents for malignant obstructive jaundice: a review. World J. Gastroenterol. 6 (2000) 643-646
45. Silvis S.E., Sievert Jr. C.E., Vennes J.A., et al. Comparison of covered versus uncovered wire mesh stents in the canine biliary tract. Gastrointest. Endosc. 40 (1994) 17-21
46. Shim C.S., Cho Y.D., Kim Y.S., et al. Long term follow up results of membrane covered self expanding metal stent in patients with malignant biliary obstruction. Gastrointest. Endosc. 49 (1999) AB131
47. Machan L., Jessurun L., Hunter W., et al. Angiogenesis inhibitor-coated metallic stents in the porcine bile duct: prevention of benign reactive overgrowth. Radiology 197 Suppl. 1 (1995) 241
48. Machan L., and Hunter W. Angiogenesis inhibition as a means to prevent stent overgrowth. JVIR 8 Suppl. 1 (1997) 198-199
49. Manifold D.K., Cowling M., Maynard N., et al. Paclitaxel coated stents in oesophageal adenocarcinoma. CVIR 21 (1998) S129